COVID-19 PCR TESTING Criteria for a Free Testing Due to recent changes in Federal coverage for COVID testing, certain medical necessity criteria must now be met for free testing. Check with your insurance provider to see if your test will be covered. Payment may be due at time of testing. Covid-19 Testing To register your …
Portal Help Center HELP TOPICS FOR PARENTS 1. How To register your student 2. How to add a second student to your account 3. How to view test reports HELP TOPICS FOR TEACHERS 1. How to register for a teacher 2. How to view test results 3. How to change your account settings TOPICS FOR …
Press BIOINFRA and 20/20 GeneSystems Announce U.S. Technology License for Enhanced Multi-Cancer Early Detection Blood Test BIOINFRA Life Sciences Ltd. of Korea and 20/20 GeneSystems, Inc., jointly announce the signing of an exclusive license of certain BIOINFRA technology to 20/20 for the U.S. market. Read More Now You Can Screen for Cancer Sooner Rather Than …
Meet our Team Executive Management Jonathan Cohen President & CEO Mr. Cohen is the founder of our company and has served as Chief Executive Officer, President, and a director since its inception. He is a co-inventor of two of our most successful products, OneTest and BioCheck, and has led the commercial launch and sales of …
Investment Information Investor Portal Please enter your details to gain access to the Investor Portal:
20/20 GeneSystems We Modernize Clinical Lab Testing with Machine Learning and Real-World Data Learn More Our Products OneTestâ„¢ for Cancer OneTest is the first test of its kind to combine the results of six cancer biomarker tests (from a single blood draw) and personal health data with an artificial intelligence algorithm to calculate a probability …
Investor Relations About 20/20 GeneSystems 20/20 GeneSystems, Inc. is a U.S. based privately held corporation based in Maryland. Investment in the company is currently open for Angel, Private and Institutional investors. Investors are invited to review our current investment offering. 20/20 GeneSystems is offering investments to verified accredited investors. Prospective investors interested in learning more about the company and its products, …
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development.
